Canary Speech
Categories
Digital Health
About Us
Canary Speech is the leading AI-powered voice biomarker company, using patented real-time vocal analysis to identify cognitive and behavioral changes earlier than clinical screenings or noticeable symptoms. Our technology works quietly in the background of natural conversations, seamlessly fitting into patient-clinician interactions without disrupting communication. By analyzing subtle vocal patterns with AI machine learning, Canary Speech provides real-time insights into conditions like Anxiety, Depression, Mild Cognitive Impairment (MCI), and Alzheimer’s Disease. With no extra prompts or interruptions, our solution empowers healthcare providers and contact centers to deliver smarter, more personal care—ensuring support reaches people when it matters most.
Images
Rep/Contact Info
Jeff Adams
Co-Founder & Chief Speech Officer
Nate Blaylock
Chief Technology Officer
Caitlyn Brooksby
Vice President, Marketing & Strategic Partnerships
David Brown
Vice President, Engineering
Namhee Kwon
Vice President, Research
